EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum phoenixin-14 and phoenixin-20 concentrations in polycystic ovary syndrome: Associations with anti-Müllerian hormone and diagnostic utility

Oznur Dundar Akin, Naile Fevziye Misirlioglu, Seyma Dumur, Mete Hakan Karalok, Yeliz Cecen Donmez, Gonul Simsek, Hafize Uzun

Biomolecules and Biomedicine · 2026

DOI: 10.17305/bb.2026.14394 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules and Biomedicine, 2026. Verfasst von Oznur Dundar Akin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Faculty of Medicine, Istanbul Atlas University, Istanbul, Türkiye. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Anti-Mullerian Hormone, Peptide Hormones. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polycystic ovary syndrome (PCOS) is a complex metabolic disorder characterized by altered peptide signaling that may contribute to reproductive dysfunction, insulin resistance, and metabolic dysregulation. This case-control study investigated serum phoenixin (PNX) isoforms, phoenixin-14 (PNX-14) and phoenixin-20 (PNX-20), in women with PCOS to evaluate their associations with biochemical and hormonal markers, including anti-Müllerian hormone (AMH), and assess their diagnostic utility. Serum PNX-14 and PNX-20 levels were measured in 90 women with PCOS and 60 age-matched healthy controls. Demographic, metabolic, and hormonal parameters were compared between the groups. Statistical analyses included receiver operating characteristic (ROC) analysis, logistic regression, correlation analysis, principal component analysis (PCA)-based clustering, mediation analysis, and exploratory Random Forest analysis. Results indicated that PNX-14 and PNX-20 levels were significantly higher in women with PCOS compared to controls (p < 0.001). Both isoforms correlated positively with AMH, insulin, homeostatic model assessment for insulin resistance (HOMA-IR), and luteinizing hormone (LH), while demonstrating negative correlations with sex hormone-binding globulin (SHBG) and high-density lipoprotein (HDL) cholesterol. ROC analysis showed moderate discriminatory performance, with area under the curve (AUC) values of 0.834 for PNX-14 and 0.819 for PNX-20. Mediation analysis suggested an associative pattern among PNX isoforms, AMH, and PCOS status. PCA-based clustering identified two distinct phenotypic profiles. Random Forest analysis ranked AMH, SHBG, fasting insulin, and body mass index (BMI) as the most influential variables, with PNX isoforms demonstrating lower importance scores. In conclusion, circulating PNX-14 and PNX-20 were elevated in PCOS and associated with key reproductive and metabolic parameters, suggesting a potential complementary role within multi-marker assessment frameworks. However, given the cross-sectional design and exploratory nature of the analyses, these findings should be considered hypothesis-generating rather than causal. Future longitudinal, mechanistic, and externally validated multicenter studies are essential to further elucidate these relationships.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeAnti-Mullerian HormonePeptide HormonesHumansFemaleCase-Control StudiesAdultBiomarkersROC CurveYoung Adult

Substanzen

Anti-Mullerian HormoneBiomarkersPeptide Hormones

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Faculty of Medicine, Istanbul Atlas University, Istanbul, Türkiye.
  • Department of Biochemistry, Faculty of Medicine, Istanbul Atlas University, Istanbul, Türkiye.
  • Department of Obstetrics and Gynecology, Kartal Dr. Lütfi Kırdar City Hospital, University of Health Sciences, Istanbul, Türkiye.
  • Department of Physiology, Istanbul Atlas University, Istanbul, Türkiye.

Zitieren

APA

Akin, O. D., Misirlioglu, N. F., Dumur, S., Karalok, M. H., Donmez, Y. C., Simsek, G., & Uzun, H. (2026). Serum phoenixin-14 and phoenixin-20 concentrations in polycystic ovary syndrome: Associations with anti-Müllerian hormone and diagnostic utility. Biomolecules and Biomedicine. https://doi.org/10.17305/bb.2026.14394

Vancouver

Akin OD, Misirlioglu NF, Dumur S, Karalok MH, Donmez YC, Simsek G, et al. Serum phoenixin-14 and phoenixin-20 concentrations in polycystic ovary syndrome: Associations with anti-Müllerian hormone and diagnostic utility. Biomolecules and Biomedicine. 2026. doi:10.17305/bb.2026.14394

BibTeX
@article{Akin2026,
  author = {Akin, Oznur Dundar and Misirlioglu, Naile Fevziye and Dumur, Seyma and Karalok, Mete Hakan and Donmez, Yeliz Cecen and Simsek, Gonul and Uzun, Hafize},
  title = {Serum phoenixin-14 and phoenixin-20 concentrations in polycystic ovary syndrome: Associations with anti-Müllerian hormone and diagnostic utility},
  journal = {Biomolecules and Biomedicine},
  year = {2026},
  doi = {10.17305/bb.2026.14394}
}
Kostenlos starten →